REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugsREGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugs

For research purposes only. Full disclaimer →

Protocols
5

PT-141 experience report

Kai Crane·22 days ago
Quick question for the group - I have been reading conflicting information and would love some clarity from people with actual experience. The research papers suggest one thing but anecdotal reports vary.

Comments (7)

Beck HamiltonDEMO·2 months ago

Can you share more about your diet and training during this protocol? Those variables matter a lot for interpreting results.

1
Ray GillDEMO·about 2 months ago

Can you share more about your diet and training during this protocol? Those variables matter a lot for interpreting results.

0
Beau BrooksDEMO·about 1 month ago

Can you share more about your diet and training during this protocol? Those variables matter a lot for interpreting results.

0
August AdamsDEMO·21 days ago

Can you share more about your diet and training during this protocol? Those variables matter a lot for interpreting results.

2
Kendall VossDEMO·21 days ago

The conflicting information is real. My experience was very dose-dependent. At lower doses I felt subtle effects that built over a few hours. At higher doses the nausea was a dealbreaker. There seems to be a narrow therapeutic window for most people.

0
Lane BakerDEMO·20 days ago

One important thing the research papers miss is the timing aspect. I found that taking PT-141 about 4-6 hours before anticipated need worked best. Some people try to take it 30 minutes before and then wonder why it did not work.

0
Crew BaldwinDEMO·19 days ago

The nasal spray formulation has been significantly more convenient than SubQ injection for me. Slightly less predictable in terms of absorption but the ease of use makes compliance much better. Anyone else tried both routes?

0

Sign in to comment.